Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome

Aim. To determine the blood level of inflammatory markers, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation (AF) in combination with metabolic syndrome (MS).Material and methods. This single-stage case-control study included 677 subjects aged 35 to 65 yea...

Full description

Bibliographic Details
Main Authors: V. A. Ionin, E. I. Baraschkova, E. L. Zaslavskaya, S. E. Nifontov, E. A. Bazhenova, O. D. Belyaeva, E. I. Baranova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2021-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4343
id doaj-046c662d457b4b24924cee3dd096d851
record_format Article
spelling doaj-046c662d457b4b24924cee3dd096d8512021-07-28T14:02:42Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202021-04-0126310.15829/1560-4071-2021-43433183Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndromeV. A. Ionin0E. I. Baraschkova1E. L. Zaslavskaya2S. E. Nifontov3E. A. Bazhenova4O. D. Belyaeva5E. I. Baranova6First Pavlov State Medical UniversityFirst Pavlov State Medical UniversityFirst Pavlov State Medical UniversityFirst Pavlov State Medical UniversityFirst Pavlov State Medical University; Almazov National Medical Research CenterFirst Pavlov State Medical University; Almazov National Medical Research CenterFirst Pavlov State Medical University; Almazov National Medical Research CenterAim. To determine the blood level of inflammatory markers, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation (AF) in combination with metabolic syndrome (MS).Material and methods. This single-stage case-control study included 677 subjects aged 35 to 65 years: patients with MS (n=407), of which 128 patients with AF; comparison group — patients with AF without MS (n=75); control group — practically healthy subjects without cardiovascular diseases and metabolic disorders (n=195).Results. It was found that the blood concentration of circulating pro-inflammatory biomarkers in patients with AF and MS is higher than in patients with AF without MS: C-reactive protein (CRP) (4,43 (2,68-4,98) and 2,33 (1,08-4,7) mg/L, p<0,0001), interleukin-6 (IL-6) (2,5 (1,28-5,13) and 1,27 (0,68-2,7) pg/ml, p<0,0001) and tumor necrosis factor-α (TNF-α) (5,18 (2,63-7,32) and 3,42 (2,115,48) pg/ml, p<0,0001). The serum CRP concentration positively correlates with left (ρ=0,451, p<0,0001) and right atrial (ρ=0,412, p<0,000) volumes, as well as with the waist circumference (ρ=0,503, p<0,001) and epicardial fat thickness (ρ=0,550, p<0,001). Plasma IL-6 and serum TNF-α levels correlated to a lesser extent with parameters characterizing atrial remodeling, but had a strong positive relationship with epicardial fat thickness. According to multivariate analysis, it was found that an increase in the epicardial fat thickness had a greater effect on an increase in blood concentration of CRP, IL-6 and TNF-α, in contrast to other parameters characterizing obesity, such as body mass index and waist circumference.Conclusion. An increase in the blood concentration of proinflammatory biomarkers CRP, IL-6, and TNF-α is associated with cardiac remodeling and epicardial fat thickness in patients with MS and probably has a pathogenetic role in increasing the AF risk in this cohort of patients.https://russjcardiol.elpub.ru/jour/article/view/4343c-reactive proteininterleukin-6tumor necrosis factor-alphaatrial fibrillationmetabolic syndrome
collection DOAJ
language Russian
format Article
sources DOAJ
author V. A. Ionin
E. I. Baraschkova
E. L. Zaslavskaya
S. E. Nifontov
E. A. Bazhenova
O. D. Belyaeva
E. I. Baranova
spellingShingle V. A. Ionin
E. I. Baraschkova
E. L. Zaslavskaya
S. E. Nifontov
E. A. Bazhenova
O. D. Belyaeva
E. I. Baranova
Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
Российский кардиологический журнал
c-reactive protein
interleukin-6
tumor necrosis factor-alpha
atrial fibrillation
metabolic syndrome
author_facet V. A. Ionin
E. I. Baraschkova
E. L. Zaslavskaya
S. E. Nifontov
E. A. Bazhenova
O. D. Belyaeva
E. I. Baranova
author_sort V. A. Ionin
title Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
title_short Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
title_full Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
title_fullStr Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
title_full_unstemmed Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
title_sort biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2021-04-01
description Aim. To determine the blood level of inflammatory markers, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation (AF) in combination with metabolic syndrome (MS).Material and methods. This single-stage case-control study included 677 subjects aged 35 to 65 years: patients with MS (n=407), of which 128 patients with AF; comparison group — patients with AF without MS (n=75); control group — practically healthy subjects without cardiovascular diseases and metabolic disorders (n=195).Results. It was found that the blood concentration of circulating pro-inflammatory biomarkers in patients with AF and MS is higher than in patients with AF without MS: C-reactive protein (CRP) (4,43 (2,68-4,98) and 2,33 (1,08-4,7) mg/L, p<0,0001), interleukin-6 (IL-6) (2,5 (1,28-5,13) and 1,27 (0,68-2,7) pg/ml, p<0,0001) and tumor necrosis factor-α (TNF-α) (5,18 (2,63-7,32) and 3,42 (2,115,48) pg/ml, p<0,0001). The serum CRP concentration positively correlates with left (ρ=0,451, p<0,0001) and right atrial (ρ=0,412, p<0,000) volumes, as well as with the waist circumference (ρ=0,503, p<0,001) and epicardial fat thickness (ρ=0,550, p<0,001). Plasma IL-6 and serum TNF-α levels correlated to a lesser extent with parameters characterizing atrial remodeling, but had a strong positive relationship with epicardial fat thickness. According to multivariate analysis, it was found that an increase in the epicardial fat thickness had a greater effect on an increase in blood concentration of CRP, IL-6 and TNF-α, in contrast to other parameters characterizing obesity, such as body mass index and waist circumference.Conclusion. An increase in the blood concentration of proinflammatory biomarkers CRP, IL-6, and TNF-α is associated with cardiac remodeling and epicardial fat thickness in patients with MS and probably has a pathogenetic role in increasing the AF risk in this cohort of patients.
topic c-reactive protein
interleukin-6
tumor necrosis factor-alpha
atrial fibrillation
metabolic syndrome
url https://russjcardiol.elpub.ru/jour/article/view/4343
work_keys_str_mv AT vaionin biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT eibaraschkova biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT elzaslavskaya biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT senifontov biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT eabazhenova biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT odbelyaeva biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
AT eibaranova biomarkersofinflammationparameterscharacterizingobesityandcardiacremodelinginpatientswithatrialfibrillationandmetabolicsyndrome
_version_ 1721268759211016192